The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Article Details
- CitationCopy to clipboard
Rohrer J, Parolini O, Belmont JW, Conley ME, Parolino O [corrected to Parolini O]
The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Immunogenetics. 1994;40(5):319-24.
- PubMed ID
- 7927535 [ View in PubMed]
- Abstract
It has recently been demonstrated that mutations in the gene for Bruton's tyrosine kinase (BTK) are responsible for X-linked agammaglobulinemia. Southern blot analysis and sequencing of cDNA were used to document deletions, insertions, and single base pair substitutions. To facilitate analysis of BTK regulation and to permit the development of assays that could be used to screen genomic DNA for mutations in BTK, we determined the genomic organization of this gene. Subcloning of a cosmid and a yeast artificial chromosome showed that BTK is divided into 19 exons spanning 37 kilobases of genomic DNA. Analysis of the region 5' to the first untranslated exon revealed no consensus TATAA or CAAT boxes; however, three retinoic acid binding sites were identified in this region. Comparison of the structure of BTK with that of other nonreceptor tyrosine kinases, including SRC, FES, and CSK, demonstrated a lack of conservation of exon borders. Information obtained in this study will contribute to our understanding of the evolution of nonreceptor tyrosine kinases. It will also be useful in diagnostic studies, including carrier detection, and in studies directed towards gene therapy or gene replacement.